S
Shanghai Rightongene Biotechnology Co Ltd
SSE:688217
Shanghai Rightongene Biotechnology Co Ltd
SSE:688217
Price:
28.31
CNY
1.8%
Market Cap:
¥1.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Shanghai Rightongene Biotechnology Co Ltd
SSE:688217
|
CN |
|
Huishang Bank Corp Ltd
HKEX:3698
|
CN |
|
Sinopec Engineering Group Co Ltd
HKEX:2386
|
CN |
|
S
|
Safety Godown Co Ltd
HKEX:237
|
HK |
|
Micro-Mechanics Holdings Ltd
SGX:5DD
|
SG |
|
T
|
Torm PLC
CSE:TRMD A
|
UK |
|
Star Mica Holdings Co Ltd
TSE:2975
|
JP |
|
Indal Aluminium Industry Tbk PT
IDX:INAI
|
ID |
|
Adairs Ltd
ASX:ADH
|
AU |
|
S
|
Shanghai Fudan Forward S&T Co Ltd
SSE:600624
|
CN |
|
C
|
China Tianrui Group Cement Co Ltd
F:T18
|
CN |
|
F
|
Fortis Healthcare Ltd
NSE:FORTIS
|
IN |
|
Big Rock Brewery Inc
TSX:BR
|
CA |
|
Duran Dogan Basim Ve Ambalaj Sanayi AS
IST:DURDO.E
|
TR |
|
Vonex Ltd
ASX:VN8
|
AU |
|
Nigbas Nigde Beton Sanayii ve Ticaret AS
IST:NIBAS.E
|
TR |
|
L
|
Lypsa Gems & Jewellery Ltd
NSE:LYPSAGEMS
|
IN |
|
T
|
Triton Development SA
WSE:TRI
|
PL |
|
Aeon Metals Ltd
ASX:AML
|
AU |
|
CMTSU Liquidation Inc
OTC:CBRI
|
US |
|
MHM Automation Ltd
NZX:MHM
|
NZ |
|
WhiteHorse Finance Inc
NASDAQ:WHF
|
US |
|
Mister Car Wash Inc
NYSE:MCW
|
US |
|
Plby Group Inc
NASDAQ:PLBY
|
US |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Shanghai Rightongene Biotechnology Co Ltd's stock price target?
Not Available
Shanghai Rightongene Biotechnology Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Shanghai Rightongene Biotechnology Co Ltd's Revenue forecast?
Projected CAGR
37%
37%
For the last 5 years the compound annual growth rate for Shanghai Rightongene Biotechnology Co Ltd's revenue is -1%. The projected CAGR for the next 2 years is 37%.
